Cargando…

Effect of Rituximab on the cognitive impairment in patients with secondary progressive multiple sclerosis

BACKGROUND: The present study aimed to address the effect of Rituximab on the cognitive impairment in patients with secondary progressive MS (SPMS). METHODS: The present interventional study used a convenience sampling method to select the study participants from SPMS patients. All these patients ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salehizadeh, Saeideh, Saeedi, Roghayyeh, Sahraian, Mohammad Ali, Rezaei Aliabadi, Hossein, Hashemi, Seyedeh Nafiseh, Eskandarieh, Sharareh, Gheini, Mohammad Reza, Shahmirzaei, Shaghayegh, Owji, Mahsa, Naser Moghadasi, Abdorreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348209/ https://www.ncbi.nlm.nih.gov/pubmed/35974939 http://dx.doi.org/10.22088/cjim.13.3.484

Ejemplares similares

Medical history risk factors in primary progressive multiple sclerosis: A case-control study
por: Maroufi, Hossein, et al.
Publicado: (2021)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran
por: Eskandarieh, Sharareh, et al.
Publicado: (2021)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

Association of body mass index and physical activity with fatigue, depression, and anxiety among Iranian patients with multiple sclerosis
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The Possible Direct Correlation between Cognitive Impairment and Fear of Catching COVID-19 among Patients with Multiple Sclerosis
por: Saeedi, Roghayyeh, et al.
Publicado: (2021)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
por: Salehizadeh, Saeideh, et al.
Publicado: (2020)

Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement
por: Shahmirzaei, Shaghayegh, et al.
Publicado: (2021)

Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey
por: Fattahi, Mohammad Reza, et al.
Publicado: (2022)

The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder
por: Rezaeimanesh, Nasim, et al.
Publicado: (2022)

Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study
por: Mortazavi, Seyyed Hosein, et al.
Publicado: (2023)

Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2015)

Can multiple sclerosis as a cognitive disorder influence patients’ dreams?
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

Evaluating the relationship between emotional intelligence and cognitive disorders in patients with Multiple Sclerosis
por: Owji, Mahsa, et al.
Publicado: (2018)

The prevalence of multiple sclerosis in Tehran, Iran, in 2020
por: Eskandarieh, Sharareh, et al.
Publicado: (2023)

Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2021)

Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study
por: Kamali, Hoda, et al.
Publicado: (2022)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS)
por: GHAJARZADEH, Mahsa, et al.
Publicado: (2014)

Recurrent isolated optic neuritis: A study on 22 patients
por: Arzani, Mahsa, et al.
Publicado: (2017)

Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2013)

Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional study
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases
por: Seyed Ahadi, Maral, et al.
Publicado: (2020)

Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
por: Azadvari, Mohaddeseh, et al.
Publicado: (2020)

Characteristics of COVID-19 in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder
por: Eskandarieh, Sharareh, et al.
Publicado: (2019)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran
por: ESKANDARIEH, Sharareh, et al.
Publicado: (2017)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Prevalence of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Is anemia a probable cause of fatigue in patients with multiple sclerosis?
por: Mir-Reza, Soha, et al.
Publicado: (2013)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue
por: Razeghi-Jahromi, Soodeh, et al.
Publicado: (2020)

Psychometric properties of the Persian version of emotions and attitudes towards MRI” (MRI-EMA)
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1df8ajaipukl0ocog1ci9sk5lp